Given the demonstrated roles of RECQ1 in repairing DNA damage caused by chemotherapeutic agents such as ionizing radiation, camptothecin, and temozolomide, overexpression of RECQ1 may provide a survival advantage to melanoma cells by promoting the ability of cancer cells to tolerate genotoxic stress. This evidence concerns the gene RECQL and melanoma.